liprotamase

Given the current share price for Anthera Pharmaceuticals Inc (NASDAQ: ANTH), H.C. Wainwright’s Andrew S. Fein believes the market appears to have “written off both the lupus and the CF programs.” Fein maintains a Buy rating on the company, while lowering the price target from $10...